Reprogram Biosciences raised $6M in Seed funding to support its oncology development, led by Unshackled Ventures, 1517 Fund, and Narya.
Amount Raised
$6 Million
Round Type
Seed
CaliforniaBiotechnologyHealth CareTherapeuticsInvestors
Description
Reprogram Biosciences, a San Carlos, CA-based preclinical oncology biotechnology company, raised an undisclosed amount in Seed funding. The funding brings the total amount to $6M. The company plans to use the funds for the continued development of its lead program and expansion of its AI discovery engine. Investors include Unshackled Ventures, 1517 Fund, and Narya.
Quick answer
Reprogram Biosciences raised $6 Million in a Seed round, dated May 29, 2026. Investors: Unshackled Ventures, 1517 Fund and Narya. Reprogram Biosciences is based in California, United States.
- How much did Reprogram Biosciences raise?
- Reprogram Biosciences raised $6 Million in a Seed round on May 29, 2026.
- Who invested in Reprogram Biosciences?
- Unshackled Ventures, 1517 Fund and Narya are named as investors in this round.
- What does Reprogram Biosciences do?
- Reprogram Biosciences is a preclinical oncology biotechnology company that is developing a new class of therapeutics based on in situ cell reprogramming.
- Where is Reprogram Biosciences based and how big is it?
- Reprogram Biosciences is based in California, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Reprogram Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Cue Biopharma raised $50M on July 13, 2026.
- Privo Technologies raised $1.2M (Grant) on July 12, 2026.
- Respiro Diagnostics raised $1.3M (Pre-Seed) on July 8, 2026.
- Allotera Therapeutics raised $35M (Funding Round) on July 8, 2026.
- Alchemab Therapeutics raised $33M (Series A) on July 8, 2026.
- Cyllene raised $38M (Series C) on July 7, 2026.
Who to call at Reprogram Biosciences, and when
A new round usually means Reprogram Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Reprogram Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Reprogram Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Reprogram Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Reprogram Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Reprogram Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.